CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Revenue:
Total revenue	$ 915,527	$ 841,661	$ 2,759,352	$ 2,538,756
Cost of Revenue:
Cost of revenue	367,545	335,035	1,095,549	1,019,345
Gross profit	547,982	506,626	1,663,803	1,519,411
Expenses:
Sales and marketing	135,698	130,021	424,034	392,570
General and administrative	89,034	83,764	248,804	243,201
Research and development	47,967	48,013	139,139	211,402
Income from operations	275,283	244,828	851,826	672,238
Interest expense	(8,647)	(10,998)	(32,316)	(26,311)
Interest income	1,255	353	1,998	830
Income before provision for income taxes	267,891	234,183	821,508	646,757
Provision for income taxes	55,660	53,245	170,987	139,875
Net income attributable to IDEXX Laboratories, Inc. stockholders	$ 212,231	$ 180,938	$ 650,521	$ 506,882
Earnings per Share:
Basic (in USD per share)	$ 2.55	$ 2.17	$ 7.83	$ 6.04
Diluted (in USD per share)	$ 2.53	$ 2.15	$ 7.75	$ 5.97
Weighted Average Shares Outstanding:
Basic (in shares)	83,097	83,247	83,058	83,855
Diluted (in shares)	83,993	84,113	83,990	84,858
Product revenue
Revenue:
Total revenue	$ 521,489	$ 481,004	$ 1,568,111	$ 1,451,899
Cost of Revenue:
Cost of revenue	178,527	158,554	532,136	487,948
Service revenue
Revenue:
Total revenue	394,038	360,657	1,191,241	1,086,857
Cost of Revenue:
Cost of revenue	$ 189,018	$ 176,481	$ 563,413	$ 531,397